| Target Price | $85.68 |
| Price | $57.34 |
| Potential | 49.42% |
| Number of Estimates | 37 |
| 37 Analysts have issued a price target Nike 2026 . The average Nike target price is $85.68. This is 49.42% higher than the current stock price. The highest price target is $126.00 119.74% , the lowest is $38.38 33.07% . | |
| A rating was issued by 44 analysts: 26 Analysts recommend Nike to buy, 16 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Nike stock has an average upside potential 2026 of 49.42% . Most analysts recommend the Nike stock at Purchase. |
41 Analysts have issued a sales forecast Nike 2026 . The average Nike sales estimate is $47.2b . This is 1.47% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $49.9b 7.28% , the lowest is $44.6b 4.17% .
This results in the following potential growth metrics:
| 2025 | $46.3b | 9.84% |
|---|---|---|
| 2026 | $47.2b | 1.92% |
| 2027 | $49.6b | 5.19% |
| 2028 | $52.1b | 5.03% |
| 2029 | $55.6b | 6.72% |
| 2030 | $58.8b | 5.61% |
| 2031 | $62.2b | 5.80% |
| 2032 | $65.9b | 5.94% |
41 Nike Analysts have issued a net profit forecast 2026. The average Nike net profit estimate is $2.5b . This is 1.57% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.0b 18.59% , the lowest is $2.0b 22.58% .
This results in the following potential growth metrics and future Net Margins:
| 2025 | $3.2b | 43.53% |
|---|---|---|
| 2026 | $2.5b | 22.82% |
| 2027 | $3.7b | 50.43% |
| 2028 | $4.6b | 21.90% |
| 2029 | $6.2b | 36.23% |
| 2030 | $7.0b | 12.50% |
| 2031 | $8.5b | 21.37% |
| 2032 | $9.4b | 11.44% |
| 2025 | 6.95% | 37.36% |
|---|---|---|
| 2026 | 5.26% | 24.33% |
| 2027 | 7.53% | 43.16% |
| 2028 | 8.74% | 16.07% |
| 2029 | 11.15% | 27.57% |
| 2030 | 11.88% | 6.55% |
| 2031 | 13.63% | 14.73% |
| 2032 | 14.34% | 5.21% |
41 Analysts have issued a Nike forecast for earnings per share. The average Nike EPS is $1.68 . This is 1.18% lower than earnings per share in the financial year 2025. The highest EPS forecast is $2.03 19.41% , the lowest is $1.32 22.35% .
This results in the following potential growth metrics and future valuations:
| 2025 | $2.16 | 42.09% |
|---|---|---|
| 2026 | $1.68 | 22.22% |
| 2027 | $2.53 | 50.60% |
| 2028 | $3.08 | 21.74% |
| 2029 | $4.20 | 36.36% |
| 2030 | $4.73 | 12.62% |
| 2031 | $5.74 | 21.35% |
| 2032 | $6.39 | 11.32% |
| Current | 33.73 | 43.35% |
|---|---|---|
| 2026 | 34.09 | 1.07% |
| 2027 | 22.66 | 33.53% |
| 2028 | 18.59 | 17.96% |
| 2029 | 13.65 | 26.57% |
| 2030 | 12.13 | 11.14% |
| 2031 | 10.00 | 17.56% |
| 2032 | 8.97 | 10.30% |
Based on analysts' sales estimates for 2026, the Nike stock is valued at an EV/Sales of 1.79 and an P/S ratio of 1.80 .
This results in the following potential growth metrics and future valuations:
| Current | 1.82 | 21.55% |
|---|---|---|
| 2026 | 1.79 | 1.71% |
| 2027 | 1.70 | 4.93% |
| 2028 | 1.62 | 4.79% |
| 2029 | 1.52 | 6.29% |
| 2030 | 1.44 | 5.31% |
| 2031 | 1.36 | 5.48% |
| 2032 | 1.28 | 5.60% |
| Current | 1.82 | 22.07% |
|---|---|---|
| 2026 | 1.80 | 1.45% |
| 2027 | 1.71 | 4.93% |
| 2028 | 1.63 | 4.79% |
| 2029 | 1.52 | 6.29% |
| 2030 | 1.44 | 5.31% |
| 2031 | 1.36 | 5.48% |
| 2032 | 1.29 | 5.60% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Guggenheim |
Buy
➜
Buy
|
Unchanged | Dec 19 2025 |
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Dec 19 2025 |
| Needham |
Buy
➜
Buy
|
Unchanged | Dec 19 2025 |
| Bernstein |
Outperform
➜
Outperform
|
Unchanged | Dec 19 2025 |
| Goldman Sachs |
Buy
➜
Buy
|
Unchanged | Dec 19 2025 |
| Citigroup |
Neutral
➜
Neutral
|
Unchanged | Dec 19 2025 |
| B of A Securities |
Buy
➜
Buy
|
Unchanged | Dec 19 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Guggenheim:
Buy
➜
Buy
|
Dec 19 2025 |
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Dec 19 2025 |
|
Unchanged
Needham:
Buy
➜
Buy
|
Dec 19 2025 |
|
Unchanged
Bernstein:
Outperform
➜
Outperform
|
Dec 19 2025 |
|
Unchanged
Goldman Sachs:
Buy
➜
Buy
|
Dec 19 2025 |
|
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Dec 19 2025 |
|
Unchanged
B of A Securities:
Buy
➜
Buy
|
Dec 19 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


